MARKET

CRL

CRL

Charles Riv Labs Intl Inc
NYSE
242.92
+1.84
+0.76%
Closed 13:01 11/25 EST
OPEN
241.03
PREV CLOSE
241.08
HIGH
243.27
LOW
239.43
VOLUME
124.51K
TURNOVER
0
52 WEEK HIGH
385.11
52 WEEK LOW
181.36
MARKET CAP
12.36B
P/E (TTM)
28.61
1D
5D
1M
3M
1Y
5Y
Insider Sell: Charles River Laboratories International
Insider Sell: Charles River Laboratories International
MT Newswires · 11/17 17:41
Charles River Laboratories to Present at November Investor Conferences
WILMINGTON, Mass., November 14, 2022--Charles River Laboratories To Present At November Investor Conferences
Business Wire · 11/14 13:00
Charles River Laboratories expands cell therapy manufacturing capacity
Seekingalpha · 11/07 16:14
Charles River Laboratories Expands Cell Therapy Manufacturing Facility in Tennessee
Charles River Laboratories Expands Cell Therapy Manufacturing Facility in Tennessee
MT Newswires · 11/07 13:05
Charles River Announces Cell Therapy Manufacturing Capacity Expansion, Reinforcing Commitment to CDMO Clients
MEMPHIS, Tenn., November 07, 2022--Charles River Laboratories International, Inc. (NYSE: CRL) today announced the expansion of its cell therapy contract development and manufacturing (CDMO) facility in Memphis, Tenn. The expanded space is suitable for clin...
Business Wire · 11/07 13:00
Analyst Ratings for Charles River
Benzinga · 11/03 14:33
JP Morgan Maintains Overweight on Charles River, Lowers Price Target to $275
Benzinga · 11/03 14:25
Credit Suisse Maintains Outperform on Charles River, Lowers Price Target to $280
Benzinga · 11/03 12:41
More
About CRL
Charles River Laboratories International, Inc. is a full service, non-clinical contract research company. The Company provides research models required in research and development of new drugs, devices, and therapies. The Company's segments include Research Models and Services (RMS), Discovery and Safety Assessment (DSA), and Manufacturing Solutions (Manufacturing). The RMS segment includes the research models, research model services, and research and GMP-compliant cells businesses. The DSA segment includes services required to take a drug through the early development process, including discovery services, which are non-regulated services to assist clients with the identification, screening, and selection of a lead compound for drug development, and regulated and non-regulated (Good Laboratory Practice (GLP) and non-GLP) safety assessment services. The Manufacturing segment includes Microbial Solutions, Biologics Solutions (Biologics), and Avian Vaccine Services (Avian).

Webull offers kinds of Charles River Laboratories Intl. Inc stock information, including NYSE:CRL real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CRL stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading CRL stock methods without spending real money on the virtual paper trading platform.